MACK News and Press, Merrimack Pharmaceuticals Inc. From 05/04/23

2023-05-04 17:47:44 ET Merrimack Pharmaceuticals press release ( NASDAQ: MACK ): Q1 GAAP EPS of $0.02. Merrimack reported a gain on the sale of assets for the first quarter ended March 31, 2023, of $139 thousand, attributable to an asset purchase option agreement on a pr...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its first quarter 2023 financial results for the period ended March 31, 2023. “During the first quarter of 2023 our operating expenses remained consistent with pr...

2023-03-09 16:58:50 ET Merrimack Pharmaceuticals press release ( NASDAQ: MACK ): FY GAAP EPS of -$0.11. As of December 31, 2022, Merrimack had cash and cash equivalents of $19.4 million, compared to $14.2 million as of December 31, 2021 For further details see: M...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its full year 2022 financial results for the period ended December 31, 2022. “We are encouraged by the results of the NAPOLI 3 trial as reported by Ipsen in Novembe...

Summary In December 2022, MACK got positive clinical results for its Phase III clinical trial of Onivyde in first line pancreatic cancer. A $225m milestone from Ipsen will be triggered on approval, which corresponds to about $16.75 per basic share. After adjusting for NOLs, tax inte...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (the “ Company ” or “ Merrimack ”), announced today that its Board of Directors (the “ Board ”) has extended the Section 382 net operating loss rights plan (the “ Plan ”) that wa...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 15, 2022 – USA News Group –  Roughly five years after selling its flagship cancer asset Onivyde from to French biotech giant Ipsen S.A. for approximately $1 billi...

Palm Beach, FL – November 10, 2022 – FinancialNewsMedia.com News Commentary – The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market competition, the market participants are implementing methods including increased ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: rafapress / Shutterstock.com Upstart (NASDAQ: UPST ) stock is sliding lower on Wednesday following a poor performance in the third quarter of 2022 and a weak outlook. Let’s start with that out...

MACK Stock Explodes 240%+ Overnight, Here Are 3 Penny Stocks To Watch Now Thanks to the 2022 stock market crash, there are plenty of penny stocks to watch. The broad market sell-off has taken even some of the most popular names and sent them below the $5 mark. That might be bad for ...